The abstract reveals a lack of specific drug recommendations for psychotic depression, suggesting standard antidepressants may work differently when psychosis is present. Understanding the distinct neurobiological pathways could inform targeted treatment approaches for this severe depression subtype. Gap type: open_question Source paper: Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis. (None, None, PMID:38360024)
Landscape Summary: What neurobiological mechanisms underlie differential drug efficacy in psychotic versus non-psychotic depression? is a 0.79 priority gap in neuropsychiatry. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What neurobiological mechanisms underlie differential drug efficacy in psychotic versus non-psychotic depression? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: